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Background: The natural history and transmission patterns of 
endemic human coronaviruses are of increased interest following the 
emergence of severe acute respiratory syndrome coronavirus-2 
(SARS-CoV-2). 
Methods: In rural Kenya 483 individuals from 47 households were 
followed for six months (2009-10) with nasopharyngeal swabs 
collected twice weekly regardless of symptoms. A total of 16,918 
swabs were tested for human coronavirus (hCoV) OC43, NL63 and 
229E and other respiratory viruses using polymerase chain reaction. 
Results: From 346 (71.6%) household members, 629 hCoV infection 
episodes were defined, with 36.3% being symptomatic: varying by 
hCoV type and decreasing with age. Symptomatic episodes (aHR=0.6 
(95% CI:0.5-0.8) or those with elevated peak viral load (medium 
aHR=0.4 (0.3-0.6); high aHR=0.31 (0.2-0.4)) had longer viral shedding 
compared to their respective counterparts. Homologous reinfections 
were observed in 99 (19.9%) of 497 first infections. School-age children 
(55%) were the most common index cases with those having medium 
(aOR=5.3 (2.3 – 12.0)) or high (8.1 (2.9 - 22.5)) peak viral load most 
often generating secondary cases. 
Conclusion: Household coronavirus infection was common, 
frequently asymptomatic and mostly introduced by school-age 
children. Secondary transmission was influenced by viral load of index 
cases. Homologous-type reinfection was common. These data may be 
insightful for SARS-CoV-2.
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Introduction
Four endemic species of human coronavirus (hCoV), HKU1, 
OC43, NL63 and 229E, are widespread and associated 
primarily with mild acute respiratory illness1. Infections with 
endemic hCoVs are reportedly more severe in young children 
and the elderly2,3. In the last two decades, three new members 
of this virus family have emerged as human pathogens; severe 
acute respiratory syndrome coronavirus (SARS-CoV)4, Middle 
East respiratory syndrome coronavirus (MERS-CoV)5 and most 
recently SARS-CoV-26. The pandemic spread and continued cir-
culation beyond the initial wave of infection suggests a poten-
tial for SARS-CoV-2 to become resident within the human 
population. A focus on the natural history and transmission 
characteristics of current little-studied endemic species of 
hCoV may give insight to the future behaviour of this emergent 
relative7.
Using data from a study of 47 households in rural Kenya, we 
have previously reported baseline data on the occurrence of 
hCoV8 and a detailed analysis of reinfection with hCoV-NL639. 
In the present study, we investigate the natural history of infec-




This study utilizes data from a prospective household-based 
cohort study conducted in one administrative location within the 
Kilifi health and demographic surveillance system (KHDSS)8,10 
on the Kenyan coast. The study design and methods have been 
described elsewhere8,11. Briefly, with a primary objective of 
characterising ‘who infects whom’ with respiratory syncytial 
virus (RSV), households with an infant born after the end of the 
2008/2009 RSV season (referred to as the study infant) and 
at least one elder sibling (aged <13 years) were enrolled. The 
study period spanned a complete RSV season from 8th December 
2009 to 5th June 2010. Nasopharyngeal specimens (NPS) were 
collected from all household members irrespective of symptoms, 
once a week in the first four weeks and twice-a-week thereaf-
ter until the study end. A household was defined as members 
(who need not be related) of one or more building units who 
share the same cooking facility. The study had a good reten-
tion rate (>80%) of households and of individuals over the study 
period11.
The study was approved by the Kenyan National Ethical 
Review Committee and the University of Warwick’s Bio-
medical Research Ethical Committee in the United Kingdom. 
Individual written informed consent was obtained from all 
study participants aged ≥18 years. For those <18 years old, 
written consent was obtained from the parent or guardian.
Molecular testing of the NPS collections using multiplex 
RT-PCR assay
A previously described real time multiplex RT-PCR (mPCR) 
assay with targets for 15 respiratory viruses was used12. The target 
pathogens were human coronavirus (hCoV species (also called 
types) OC43, NL63 and 229E), RSV A and B, rhinovirus 
(RV), adenovirus (AdV), parainfluenza virus (types 1–4), influ-
enza virus (types A, B and C) and human metapneumovirus 
(hMPV). A preliminary screen of the NPS showed the last 
three virus groups were uncommon during the surveillance 
period and hence not screened for the remainder of the NPS 
collections8. A specimen with a cycle threshold (Ct) value of 
≤35.0 for a specific virus target was considered positive.
Statistical analysis
Data analyses were undertaken in STATA Version 13.0 (Stata-
Corp, College Station, Texas, USA). Descriptive statistics for 
continuous variables are presented as mean (± standard devia-
tion) and median (interquartile range (IQR)). Categorical vari-
ables were summarised using counts and proportions and the 
chi-square test of association was used to examine the inde-
pendence. The Mood’s median test was used to investigate 
equality of median times across levels of categorical variables. 
Two or more groups were compared using test for equality of 
proportions.
Type-specific individual hCoV infection episodes were defined 
as a period with positive mPCR result(s) of the same type with 
no more than 14 days apart13. Episodes where no samples were 
collected and tested for >7 days before or after the infection 
episode were considered left- or right-censored, respectively. 
An episode was considered symptomatic if the individual 
was identified with any of the following symptoms during 
the infection episode; cough, runny nose, sore throat, nasal 
flaring, indrawing, crackles, wheeze, fever, unable to feed, 
head nodding, lethargy, unable to talk, cyanosis or difficulty 
breathing. Co-infection was assigned when within the hCoV 
infection episode an NPS collection was mPCR positive for a 
different hCoV species or another of the viruses tested, namely; 
RSV, RV, or AdV. Detection of two or more individual infec-
tion episodes by the same hCoV type in a household within 
a span of 14 days constituted a household outbreak. For each 
household hCoV introduction, a primary (index) case was 
defined as the first person(s) to test positive for hCoV by 
mPCR while secondary case(s) were the rest of the members 
who are part of the same household outbreak. For individu-
als with multiple hCoV infection episodes, reinfections were 
classified as either homologous (same hCoV species) or het-
erologous (different hCoV species) with respect to previously 
detected species during the study period. As an example, if an 
individual has three infections in the temporal order OC43, 
NL63 and OC43, then the second infection episode would 
be heterologous to the first, and the third homologous to the 
first infection episode and heterologous to the second episode.
Durations of virus shedding were estimated using a midpoint 
method which was defined as the period starting midway between 
the first positive sample and the previous negative sample 
and ending midway between the last positive sample and the 
subsequent negative sample. Further details on this approach are 
provided elsewhere13. Kaplan Meir (KM) curves were used to 
describe the survival functions (time to end of virus shedding) 
by different categorical variables across the three endemic 
hCoV types. Adjusted hazard ratios (aHR) obtained from 
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multivariable Cox proportional hazards (PH) models were 
used to estimate the influence of several factors on the dura-
tion of shedding and symptoms. Logistic regression models were 
used to identify risk factors for spread of infection from the pri-
mary cases to other household members. The risk factors con-
sidered were age, sex, household size, presence of respiratory 
symptoms, presence of other respiratory pathogens and peak 
viral load in an infection episode. The peak/highest viral load 
was defined as the lowest Ct value in an individual infection 
episode and was categorised into three levels; low (>=30), 
medium (20–29) and high (<20). To account for clustering either 
at individual or household level, robust cluster variance esti-




A total of 483 individuals from 47 households had NPS col-
lected over the six-month period. The mean number of house-
hold members was 10.5 (SD=6.5) classified into small 
(4–7 members), medium (8–16 members) and large (17– 37 mem-
bers). The median age of participants at the start of sampling 
was 10.7 years (IQR: 4.0 – 23.4). The cohort had 214 (44.3%) 
male participants. Of the 47 study infants, the average age at 
the start of the study was 3.9 (SD=2.6) months and 22 (46.8%) 
of the infants were males. A total of 16,918 NPS from 483 
individuals were successfully tested for OC43, 229E and 
NL63. The median number of NPS collected from study 
participants was 41 (IQR: 30 - 44).
Of the 16918 samples tested, 1274 (7.5%) were positive for 
any of the three hCoV: 651 (3.8%), 418 (2.5%) and 241 (1.4%) 
samples were positive for OC43, NL63 and 229E, respec-
tively. Seven (0.04%) NPS collections were positive for both 
OC43 and NL63, 17 (0.1%) were positive for both OC43 and 
229E and 13 (0.08%) were positive for both NL63 and 229E. 
Only one sample was positive for all three hCoV tested. Higher 
individual crude attack rates (Table 1) were seen in school 
going children (129/169; 76.3%), males (160/214; 74.8%) 
and younger individuals (<1 year; 42/55, 76.4%, 1–4 years; 
Table 1. Crude individual attack rates for the hCoV infections by various characteristics.
Characteristics Any hCoV OC43 NL63 229E
Categories N n % n % n % n %
Overall 483 346 71.6 215 44.4 163 33.7 119 24.6
Age in years <1 55 42 76.4 30 54.6 16 29.1 16 29.1
1–4 82 64 78.0 45 54.9 28 34.2 24 29.3
5–14 163 125 76.7 83 50.9 65 39.9 40 24.5
15–39 141 93 66.0 51 36.2 42 29.8 29 20.6
≥40 42 22 52.4 6 14.3 12 28.6 10 23.8
Relation to the 
study infant
Self 47 37 78.7 27 57.5 13 27.7 15 31.9
Sibling 162 124 76.5 87 53.7 55 34.0 40 24.7
Cousin 124 91 73.4 56 45.2 51 41.1 28 22.6
Mother 46 27 58.7 16 34.8 13 28.6 11 23.9
Father 30 17 56.7 7 23.3 7 23.3 5 16.7
Other HH 
members
74 50 67.6 22 29.7 24 32.4 20 27.0
Sex Female 269 186 69.1 121 45.0 89 33.1 65 24.2
Male 214 160 74.8 94 43.9 74 34.6 54 25.2
School going No 314 217 69.1 128 40.8 104 33.1 76 24.2





4 to 7 95 75 79.0 50 52.6 37 39.0 21 22.1
8 to10 120 77 64.2 53 44.2 29 24.2 26 21.7
11 to 16 144 97 67.4 48 33.3 49 34.0 40 27.8
17 to 37 124 97 78.2 64 51.6 48 38.7 32 25.8
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64/82, 78.0% and 5–14 years; 125/163, 76.7%) (Extended data: 
Supplementary Figure S1) and individuals residing small 
(75/95, 79.0%) and large households (97/124, 78.2%).
Symptomatic individuals contributed to 410 (32.2%) of the 
1274 samples that were positive for any HCoV and 3150 
(20.1%) of 15645 hCoV negative samples. Symptomatic indi-
viduals contributed to 240 (36.9%), 132 (31.6%) and 47 (19.5%) 
of the total number of samples that tested positive for OC43, 
NL63 and 229E, respectively, and correspondingly 3320 (20.4%), 
3428 (20.8%) and 3513 (21.1%) of samples that tested nega-
tive. There was a statistically significant association between the 
presence of respiratory symptoms during sampling times and 
detection of any hCoV ( 2(1)χ  = 102.9, p-value <0.001), OC43 
( 2(1)χ  = 102.1, p-value <0.001) and NL63 (
2
(1)
χ  = 28.6, 
p-value <0.001) but not 229E ( 2(1)χ  = 0.35, p-value =0.555). 
HCoV infection episodes
The pattern of shedding of each of the three hCoV types and 
of all hCoVs, is displayed in Figure 1. Over the study period, 
346 (71.6%) of the 483 individuals experienced one or more 
hCoV infection episodes. The total number of individual 
infection episodes was 260 for OC43, 216 for NL63, 140 for 
229E and 629 for any hCoV type. Of these the number of 
episodes symptomatic was 116 (44.5%) for OC43, 85 (39.4%) 
for NL63, 35 (25.0%) for 229E and 228 (36.3%) for any 
hCoV type. The proportion of symptomatic episodes differed 
by hCoV type ( 2( )3χ  = 15.7, p-value =0.001) and by age for any 
hCoV type ( 2( 4)χ  = 99.35, p-value < 0.001) and each of the 
three hCoV types (OC43; 2( 4)χ  = 54.4, p-value <0.001, NL63; 
2
( 4)
χ  = 34.7, p-value <0.001 and 229E; 2
( 4)
χ  = 25.5, p-value 
<0.001). Of the total episodes, 29 (11.2%), 51 (23.6%), 28 (20%) 
and 105 (16.7%) of OC43, NL63, 229E or any hCoV infec-
tion episodes, respectively were either right or left-censored 
and were excluded in survival analysis.
On average, the peak viral load of the individual infection 
episodes was higher in symptomatic compared to asymptomatic 
episodes (Figure 2). This was supported by linear regression 
model, adjusted for age, fitted on the peak viral load showing 
symptomatic infection episodes had a higher viral load (lower 
Ct values) compared to asymptomatic episodes for OC43 
(β = –4.16, 95% CI= -5.55, -2.77, p-value<0.001), NL63 
(β = –2.74, 95% CI= -5.06, -0.43, p-value=0.020), 229E 
(β = –5.79, 95% CI= -9.88 , -1.70, p-value=0.006) and any 
hCoV (β = –3.11, 95% CI= -4.50, -1.72, p-value <0.001).
Figure 1. Individual infection episodes showing the duration of shedding hCoV type. The grey lines indicate duration of the episodes, 
dots indicate positive samples within an episode and the crosses at both ends of the line denote the start and end of the infection episodes. 
For the first three graphs (OC43, NL63 and 229E) symptomatic episodes are shown by red filled dots while asymptomatic episodes are 
shown by blue unfilled dots. In the final graph, red, blue, green and yellow dots indicate samples positive for OC43, NL63, 229E and HCoV-
HCoV coinfection. Filled dots indicate symptomatic episodes while unfilled dots are asymptomatic episodes.
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Durations of hCoV shedding and factors influencing 
shedding patterns
The duration of virus shedding varied by hCoV type with the 
longest median duration observed for OC43 (7.5 days, IQR: 
3.5 -13.5) and the shortest median duration for 229E (3.5 days, 
IQR: 3.5 - 7.0) (Figure 3). The results of the survival analysis 
of shedding durations are shown in Table 2. For OC43, the 
rate of recovery from an infection episode, compared to chil-
dren aged <1 year, was higher in children aged 5–14 years 
(aHR=2.21, 95% CI: 1.40 – 3.47, p-value=<0.001), those aged 
15–39 years (aHR=1.72, 95% CI: 1.05 – 2.83, p-value=0.032) 
and older adults 40 years or more (aHR=3.44, 95% CI: 1.97 
– 6.01, p-value <0.001). Age dependence for duration of 
infection episodes was not observed for NL63, 229E and 
pooled hCoV type analysis. Lower rates of recovery from 
OC43 virus shedding (i.e. longer shedding durations) were 
observed among symptomatic (compared to asymptomatic) 
individuals (aHR=0.56, 95% CI: 0.39 - 0.81, p-value=0.002), 
and individuals with medium peak viral load (aHR=0.32, 
95% CI: 0.22-0.47, p-value <0.001) and high peak viral load 
(aHR= 0.22, 95% CI: 0.14-0.36, p-value <0.001) compared 
to individuals with low peak viral load. Recovery rates from 
NL63 infection episode was dependent on detection of other 
viral pathogens within the same infection episode (aHR= 
0.54, 95% CI: 0.34 - 0.87, p-value= 0.011), being sympto-
matic (aHR= 0.67, 95% CI: 0.50 - 0.90, p-value=0.009), and 
medium (aHR= 0.49, 95% CI: 0.33 - 0.74, p-value=0.001) and 
high (aHR=0.37, 95% CI: 0.24 - 0.59, p-value <0.001) peak 
viral load in an infection episode. For 229E, having medium 
(aHR=0.49, 95% CI: 0.30 - 0.78, p-value=0.003) and 
high (aHR=0.21, 95% CI: 0.11 - 0.40, p-value=<0.001) peak 
viral load significantly affected the rate of recovery from an 
infection episode. The KM curves for each factor are presented 
in Extended data: Supplementary Figures S2–S5. 
Duration of symptomatic period
The median duration of symptoms (Extended data: Supplemen-
tary Table S1) was 7.0, 4.0, 3.5 and 4.0 days, for OC43, NL63, 
229E and any hCoV, respectively. For any hCoV median dura-
tions tended to decline with increasing age, increase in the 
presence of other respiratory viruses and increase for high 
peak viral load. There was some variation between hCoV type. 
The rate of recovery from symptoms (Extended data: Sup-
plementary Table S2) within any hCoV infection episodes 
increased with age; 1–4 years (aHR=1.45, 95% CI: 1.03 - 2.04, 
p-value=0.034), 5–14 years (aHR=1.64, 95% CI:1.12 - 2.39, 
p-value=0.010), 15–39 years (aHR=2.25, 95% CI: 1.30 – 3.89, 
Figure 2. Violin plots showing the distribution of the peak viral load (expressed in Ct values) across infection episodes by hCoV 
type and symptomatic status.
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p-value=0.003); 40 years and above (aHR=1.61, 95% CI: 1.10 
– 2.37, p-value=0.014). A similar pattern was observed on 
OC43 alone out of the three hCoVs. Infection episodes with 
a coinfection with another virus had lower rates of recovery 
from symptoms for 229E (aHR=0.33, 95% CI: 0.17 - 0.63, 
p-value=0.001) and any hCoV (aHR=0.71, 95% CI: 0.55 - 
0.91, p-value=0.006). The rate of symptoms clearance within 
OC43 infection episodes was influenced by medium peak 
viral load (aHR=0.15, 95% CI 0.07 - 0.31, p-value < 0.001) 
and high peak viral load (aHR=0.14 95% CI: 0.07 - 0.29, 
p-value<0.001). Similarly, a lower recovery rate was observed 
for any hCoV infection episodes with medium peak viral load 
(aHR 0.44, 95% CI: 0.29 - 0.68, p-value < 0.001) and high 
peak viral load (aHR=0.35, 0.23 - 0.54, p-value<0.001). 
Reinfection
Details of reinfections in the study cohort are given in Table 3. 
Of 483 study individuals, 346 (71.6%) experienced one or 
more infection episodes and 171 (35%) experienced multi-
ple infection episodes for any hCoV type. Of the 215, 163, and 
119 individuals who had first infections of OC43, NL63 and 
229E, respectively, a corresponding 35 (16.3%), 44 (27.0%) and 
20 (16.8%), experienced one or more homologous reinfections. 
In summation, a total of 497 first infections with OC43, NL63 
and 229E were observed of which 99 (19.9%) were re-infected 
at least once with the homologous type. Of the 629 episodes, 
346 (55.0%) were first and 283 (45.0%) secondary, infections 
and 154/283 (54.4%) reinfections were of homologous type. 
Analysing the total infections by type, the proportion of homol-
ogous reinfection episodes varied ( 2(1)χ  = 6.12, p-value =0.047) 
by type (17.3% of 260 OC43 episodes, 24.5% of 216 NL63 epi-
sodes and 15.0% of 140 episodes due to 229E). In addition, 
48 (31.2%) of the 154 homologous reinfection episodes due to 
any hCoV were symptomatic, compared to 56 (43.4%) of 
the 129 heterologous reinfections. There was no difference 
( 2(1)χ  = 0.09, p-value =0.764) in the median time to reinfec-
tion between homologous (41 days, IQR: 19–73 days) and 
heterologous (40 days, IQR: 23–60 days) infection epi-
sodes. In the period between end of the first infection episode 
and start of the first reinfection episode, a total of 16 (9.4%) 
did not have any swabs taken, possibly indicating a continua-
tion of the first episode, while 9 (5.3%), 8 (4.7%), 14 (8.2%) 
and 124 (72.5%) had 1,2,3 and ≥4 PCR negative samples 
respectively out of the 171 individuals with multiple infections.
There was no difference in the proportion of symptomatic 
episodes in the first infection episodes (124/346, 35.8%) com-
pared to reinfections (104/283, 36.8%) (p-value=0.7952). Dis-
aggregation of symptomatic infection episodes by hCoV type 
showed that the contribution of each pathogen to the first 124 
symptomatic episodes varied; OC43 (58.1%), NL63 (26.6%), 
229E (14.5%) and hCoV-hCoV coinfection (0.8%). Simi-
larly, out of the 104 symptomatic reinfections episodes, there 
was a variation in the proportion of hCoV type; OC43 (36.5%), 
NL63 (44.2%), 229E (12.5%) and hCoV- hCoV coinfection 
(6.7%).
Transmission of hCoV in households
All the 47 households had at least one of the three hCoV 
detected while hCoV-OC43, NL63 and 229E were detected 
Figure 3. Time to recovery of hCoV infections for OC43, NL63, NL63 and any hCoV based on survival analysis (Kaplan Meir 
curves).
Page 7 of 14
Wellcome Open Research 2021, 6:27 Last updated: 17 AUG 2021
in 44 (93.6%), 33 (70.2%) and 30 (63.8%) of the households, 
respectively. There were 78, 48, 59 and 201 household intro-
ductions for OC43, NL63, 229E and any hCoV, respectively. 
Siblings and cousins, predominantly of school going age, to 
the study infants were index cases for 59.0%, 64.6%, 52.5% 
and 53.7% of OC43, NL63, 229E and any hCoV household 
introductions, respectively (Figure 4). Out of the total number 
of household introductions, 46 (59.0%), 30 (62.5%), 23 (39.0%) 
and 96 (47.8%) led to secondary infections in 35, 23, 17 and 
43 households for OC43, NL63, 229E and any hCoV, respec-
tively. The proportion of secondary infections due to the 3 hCoV 
types was significantly different across types ( 2
(2 )
χ  = 7.50, 
p-value =0.023).
The risk of generating a secondary case after introduction 
of any of the three endemic hCoV in the household was higher 
for index cases whose peak viral load was medium (aOR=5.29, 
95% CI: 2.34 – 11.96, p-value <0.001) or high (aOR=8.12, 
95% CI: 2.92 - 22.51, p-value <0.001) compared those with a 
low peak viral load. However, being a symptomatic index 
case was not associated with increased risk of infecting other 
members of the household (aOR=0.97, 95% CI: 0.42 - 2.21, 
Table 2. Factors influencing the recovery rate of hCoV infections from multivariable cox proportional hazards model analysis.
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HCoV type OC43 _ _ _ _ _ _ Ref
NL63 _ _ _ _ _ _ 1.17 
(0.95 – 1.43)
0.125






_ _ _ _ _ _ 2.64 
(1.97 – 3.55)
<0.001
Key: aHR, adjusted Hazard Ratio; hCoV-hCoV coinfection denotes infection episodes in which an individual tested positive for two or more hCoVs.
Page 8 of 14
Wellcome Open Research 2021, 6:27 Last updated: 17 AUG 2021
Table 3. Frequency distribution of individual infection episodes by hCoV type in 483 individuals from a 
household cohort in rural Kenya.






OC43 215 35 9 1 _ _ _ 45 260
NL63 163 44 8 1 _ _ _ 53 216
229E 119 20 1 _ _ _ _ 21 140
All types summation 497 99 18 2 _ _ _
Any hcoV type 
episodes
Any Homologous 66 52 25 8 2 1 154
Any infection 346 171 73 27 9 2 1 283 629
Figure 4. Frequency distribution of who brings hCoV infections in households by HCoV type.
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p-value=0.933) compared to asymptomatic index cases 
(Extended data: Supplementary Table S3). 
Discussion
Longitudinal studies of households have played an impor-
tant role in developing understanding of the epidemiology of 
respiratory viruses7,14. Here we continue this approach, report-
ing an intensive surveillance of 483 household members in 
rural coastal Kenya11, to delineate the natural history of infec-
tion and transmission patterns of three endemic coronaviruses 
(OC43, NL63 and 229E). This involved the application of 
sensitive molecular diagnostic methods7,14, and additionally 
applied sampling that was frequent and irrespective of observed 
symptoms8. The hCoV types were common in this setting 
with each of the 47 households, and about 72% of the enrolled 
household members, experiencing infection with at least one of 
three targets over the six months of the study. A note of 
caution in interpreting the results of this study is that infection 
status determined by PCR assay is not necessarily indicative 
of active infection or an individual’s infectiousness.
Crude attack rates were highest for hCoV-OC43 and lowest 
for 229E, higher in general for younger age classes (<15 years 
of age), school-age children and for males. These results are 
broadly consistent with the findings by Monto et al. who also 
found highest incidence for OC43, lowest for 229E, and higher 
incidence among those aged below 5 years for NL63 and OC437.
The three hCoV types had differing durations of shedding 
ranging from 3.5 days (229E) to 7.5 days (OC43). However, 
these median time estimates are influenced by our sampling fre-
quency: predominantly every 3–4 days. The duration of shed-
ding was longer in episodes with high peak virus load and which 
were symptomatic. Consistent with findings from other studies, 
we report occurrence of hCoV infection episodes among asymp-
tomatic individuals15–17 who had lower viral load18 and shorter 
durations of virus shedding compared to symptomatic episodes. 
Despite asymptomatic infections being predominant (>70% of 
episodes) the above findings suggest they were less likely to 
transmit infection compared to symptomatic individuals. The 
duration of symptomatic episodes was related to peak virus 
load as reported elsewhere [25] and tended to decline with 
increasing age.
Participants of all ages had appreciable risk of infection for 
the three endemic viruses suggesting previous infection does 
not provide solid immunity. This is supported by our observa-
tion that, within the short period of the study, reinfections were 
common and as frequently of homologous as heterologous 
type. Overall, 20% of individuals with a first infection of one 
or other type, were reinfected by the same type at least once, 
most commonly for type NL63 (24.5%). Homologous 
reinfections were frequently (>30%) symptomatic. We report no 
difference in the proportion of symptomatic cases between the 
first episodes and reinfection episodes and note that the time to 
reinfection with homologous was similar to heterologous epi-
sodes (~40 days). Our observations indicate that immunity to 
reinfection is commonly short lived and does not appear to 
be type specific. A recent serological study involving 10 adult 
men detected reinfections from seasonal coronaviruses but 
most frequently occurring after an interval of 12 months19. A 
limitation of our analysis is that reinfections might in fact 
have been prolonged shedding from a single infection. This 
is likely not a major effect as in most presumed reinfections 
(>70%) there were at least 4 PCR test negative results between 
episodes.
Older children (siblings and cousins) and other adults were the 
major introducers of hCoV transmission into the household 
compared to RSV transmission in the same households whereby 
older children (> 32%) were the leading primary cases11. Simi-
larly, children have been reported to form the highest propor-
tion of index cases in the USA and UK7,20. However, presence 
of older adults, children, smokers and individuals with 
chronic ailments within the households in the UK study was 
associated with increased household transmission20. Secondary 
transmission of hCoV to other household members upon intro-
duction was high (48%) for any of the three hCoVs (ranged 
from 39% to 62% across type). This differs from a recent study 
in England which concluded that the vast majority (>90%) 
of observed hCoV infections were acquired outside the 
household20. In our study, the risk of secondary transmission 
was higher among index cases with high viral loads. Interest-
ingly, there was no significant association between the pres-
ence of symptoms among index cases and the risk of secondary 
transmission, as observed elsewhere20.
In conclusion, endemic coronaviruses are common within the 
household setting, infecting all age groups, and often with-
out eliciting symptoms. Secondary transmission following 
household introduction is associated with viral load but not, it 
appears, with symptomatic status, and homologous reinfection 
is common for all hCoV types.
Data availability
Underlying data
Harvard Dataverse: Replication Data for: Infection patterns of 
endemic human coronaviruses in rural households in coastal 
Kenya”, https://doi.org/10.7910/DVN/CPJ9B421.
As the dataset contains potentially identifying information on 
participants, it is stored under restricted access. Details on 
eligibility for access and a request form are available from 
http://kemri-wellcome.org/about-us/#ChildVerticalTab_15 for 
consideration by our Data Governance Committee (dgc@kemri- 
wellcome.org).
The data codebook and scripts are openly available under the 
terms of the Creative Commons Attribution 4.0 International 
license (CC-BY 4.0).
Extended data
Harvard Dataverse: Replication Data for: Infection patterns of 
endemic human coronaviruses in rural households in coastal 
Kenya”, https://doi.org/10.7910/DVN/CPJ9B421.
This project contains the following extended data:
-  Supplementary Figures 1–5
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-  Supplementary Tables 1–3
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Synopsis: 
Nyaguthii and colleagues describe the screening of 483 individuals from 47 households for 
respiratory viruses over a 6 month period in the 2009-2010 respiratory syncytial virus (RSV) 
season. In this report, the detection data for human coronaviruses OC43, NL63 and 229E are 
described. There are some intriguing numbers on reinfection and duration of ‘shedding’ (as 
proxied using PCR positivity). The data are of interest because we have seen these types of studies 
in the developed world, but in this study, a household has, on average, over 10 individuals, and so 
these data provide a far more robust investigation of within household transmission. The data are 




There raw data linked in the manuscript is restricted access for ethical reasons, so I cannot review 
it. Is it not possible to anonymise the data and share it that way? (I appreciate that this may not be 
possible given how detailed the data are). 
 
Minor Comments:
Methods: Although the study design is previously published, a sentence on how the clinical 
data were collected would be appropriate. 
 
1. 
Methods: Why is HCoV-HKU1 not screened for? 
 
2. 
Methods: RT-PCR should read RT-qPCR. 
 
3. 
Methods: hMPV should be reannotated HMPV in line with ICTV guidance. Similarly 
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Methods: The paragraphs below the ‘Statistical analysis’ section are lacking headings. 
 
5. 
Methods: Using PCR based detection as a proxy for shedding raises an eyebrow. As the 
approach can be expected to be consistent across the viruses, the relative measures of 
shedding are likely reasonable, but the raw numbers may not be. This is briefly commented 
on in the discussion but I feel that this could be elaborated. 
 
6. 
Results: in baseline characteristics, for gender references ‘male’ is referred to when these 
were a minority in the study set. The majority population (female) should instead be 
referred to unless gender was unavailable/ not disclosed for some subjects. 
 
7. 
Results: The sentence ‘Symptomatic individuals contributed to 240…of samples that tested 




Results: There are several places where ‘any HCoV type’ is referred to, but I am not sure 
whether this is referring to specifically mixed infections- in some cases, it seems to be. Can 
this be defined somewhere? 
 
9. 
Figure 1: I cannot distinguish between open and closed dots, are they really different? (I am 
looking at a print out) 
 
10. 
Results: For the duration of shedding, if I am interpreting Fig. 1 correctly, you have some 
examples where shedding occurs for over 3 months. That is worth a sentence or two! (Also 
in the discussion) 
 
11. 
Results: Reinfection data describe occasions where individuals tested positive in sequential 
tests, but these were categorised as reinfection. On what basis was that judgement made? 
It seems counterintuitive. 
 
12. 
Results: Reinfection data describe the frequencies of reinfection with each of the three 
HCoVs studied – do these frequencies differ from the overall frequencies? 
 
13. 
Discussion: The abstract mentions SARS-CoV-2, but no parallels are made in the discussion – 
either take this out of the abstract or make an interpretation in the discussion.
14. 
 
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
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Are all the source data underlying the results available to ensure full reproducibility?
Partly
Are the conclusions drawn adequately supported by the results?
Yes
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expertise to confirm that it is of an acceptable scientific standard.
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